 | • レポートコード：MRC2102QY9827 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の非ステロイド性抗炎症薬市場について種類別（経口、注射）、用途別（変形性関節症、筋肉痛、腰痛、歯痛、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・非ステロイド性抗炎症薬市場の概要 ・世界の主要地域別非ステロイド性抗炎症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の非ステロイド性抗炎症薬市場規模2015-2026：種類別（経口、注射） ・世界の非ステロイド性抗炎症薬市場規模2015-2026：用途別（変形性関節症、筋肉痛、腰痛、歯痛、その他） ・非ステロイド性抗炎症薬の米国市場規模2015-2020 ・非ステロイド性抗炎症薬のヨーロッパ市場規模2015-2020 ・非ステロイド性抗炎症薬の中国市場規模2015-2020 ・非ステロイド性抗炎症薬の日本市場規模2015-2020 ・非ステロイド性抗炎症薬の東南アジア市場規模2015-2020 ・非ステロイド性抗炎症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・非ステロイド性抗炎症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・非ステロイド性抗炎症薬の市場動向・機会・課題 ・調査の結論 |
Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune diseases and pain diseases.
Market Analysis and Insights: Global Nonsteroidal Antiinflammatory Drugs Market
The global Nonsteroidal Antiinflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Nonsteroidal Antiinflammatory Drugs Scope and Market Size
The global Nonsteroidal Antiinflammatory Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Antiinflammatory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Nonsteroidal Antiinflammatory Drugs market is segmented into
Oral
Injection
Segment by Application, the Nonsteroidal Antiinflammatory Drugs market is segmented into
Osteoarthritis
Muscle Aches
Backaches
Dental Pain
Others
The Nonsteroidal Antiinflammatory Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Nonsteroidal Antiinflammatory Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nonsteroidal Antiinflammatory Drugs Market Share Analysis
Nonsteroidal Antiinflammatory Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nonsteroidal Antiinflammatory Drugs business, the date to enter into the Nonsteroidal Antiinflammatory Drugs market, Nonsteroidal Antiinflammatory Drugs product introduction, recent developments, etc.
The major vendors covered:
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
DOMESCO
1 Nonsteroidal Antiinflammatory Drugs Market Overview
1.1 Nonsteroidal Antiinflammatory Drugs Product Scope
1.2 Nonsteroidal Antiinflammatory Drugs Segment by Type
1.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2026)
1.2.2 Oral
1.2.3 Injection
1.3 Nonsteroidal Antiinflammatory Drugs Segment by Application
1.3.1 Global Nonsteroidal Antiinflammatory Drugs Sales Comparison by Application (2020-2026)
1.3.2 Osteoarthritis
1.3.3 Muscle Aches
1.3.4 Backaches
1.3.5 Dental Pain
1.3.6 Others
1.4 Nonsteroidal Antiinflammatory Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Nonsteroidal Antiinflammatory Drugs Price Trends (2015-2026)
2 Nonsteroidal Antiinflammatory Drugs Estimate and Forecast by Region
2.1 Global Nonsteroidal Antiinflammatory Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nonsteroidal Antiinflammatory Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Nonsteroidal Antiinflammatory Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nonsteroidal Antiinflammatory Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nonsteroidal Antiinflammatory Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Nonsteroidal Antiinflammatory Drugs Estimates and Projections (2015-2026)
2.4.3 China Nonsteroidal Antiinflammatory Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Nonsteroidal Antiinflammatory Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nonsteroidal Antiinflammatory Drugs Estimates and Projections (2015-2026)
2.4.6 India Nonsteroidal Antiinflammatory Drugs Estimates and Projections (2015-2026)
3 Global Nonsteroidal Antiinflammatory Drugs Competition Landscape by Players
3.1 Global Top Nonsteroidal Antiinflammatory Drugs Players by Sales (2015-2020)
3.2 Global Top Nonsteroidal Antiinflammatory Drugs Players by Revenue (2015-2020)
3.3 Global Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Antiinflammatory Drugs as of 2019)
3.4 Global Nonsteroidal Antiinflammatory Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Nonsteroidal Antiinflammatory Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nonsteroidal Antiinflammatory Drugs Players (Opinion Leaders)
4 Global Nonsteroidal Antiinflammatory Drugs Market Size by Type
4.1 Global Nonsteroidal Antiinflammatory Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Nonsteroidal Antiinflammatory Drugs Price by Type (2015-2020)
4.2 Global Nonsteroidal Antiinflammatory Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Nonsteroidal Antiinflammatory Drugs Price Forecast by Type (2021-2026)
5 Global Nonsteroidal Antiinflammatory Drugs Market Size by Application
5.1 Global Nonsteroidal Antiinflammatory Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Nonsteroidal Antiinflammatory Drugs Price by Application (2015-2020)
5.2 Global Nonsteroidal Antiinflammatory Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Nonsteroidal Antiinflammatory Drugs Price Forecast by Application (2021-2026)
6 United States Nonsteroidal Antiinflammatory Drugs Market Facts & Figures
6.1 United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
6.2 United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
6.3 United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
7 Europe Nonsteroidal Antiinflammatory Drugs Market Facts & Figures
7.1 Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
8 China Nonsteroidal Antiinflammatory Drugs Market Facts & Figures
8.1 China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
8.2 China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
8.3 China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
9 Japan Nonsteroidal Antiinflammatory Drugs Market Facts & Figures
9.1 Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Nonsteroidal Antiinflammatory Drugs Market Facts & Figures
10.1 Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
11 India Nonsteroidal Antiinflammatory Drugs Market Facts & Figures
11.1 India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
11.2 India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
11.3 India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Nonsteroidal Antiinflammatory Drugs Business
12.1 Sanofi S.A.
12.1.1 Sanofi S.A. Corporation Information
12.1.2 Sanofi S.A. Business Overview
12.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Products Offered
12.1.5 Sanofi S.A. Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Corporation Information
12.2.2 Novartis AG Business Overview
12.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis AG Nonsteroidal Antiinflammatory Drugs Products Offered
12.2.5 Novartis AG Recent Development
12.3 GlaxoSmithKline PLC
12.3.1 GlaxoSmithKline PLC Corporation Information
12.3.2 GlaxoSmithKline PLC Business Overview
12.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Products Offered
12.3.5 GlaxoSmithKline PLC Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Nonsteroidal Antiinflammatory Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 DOMESCO
12.5.1 DOMESCO Corporation Information
12.5.2 DOMESCO Business Overview
12.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 DOMESCO Nonsteroidal Antiinflammatory Drugs Products Offered
12.5.5 DOMESCO Recent Development
…
13 Nonsteroidal Antiinflammatory Drugs Manufacturing Cost Analysis
13.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
13.4 Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nonsteroidal Antiinflammatory Drugs Distributors List
14.3 Nonsteroidal Antiinflammatory Drugs Customers
15 Market Dynamics
15.1 Nonsteroidal Antiinflammatory Drugs Market Trends
15.2 Nonsteroidal Antiinflammatory Drugs Opportunities and Drivers
15.3 Nonsteroidal Antiinflammatory Drugs Market Challenges
15.4 Nonsteroidal Antiinflammatory Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Nonsteroidal Antiinflammatory Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) by Region (2015-2020)
Table 5. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Region (2015-2020)
Table 8. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Nonsteroidal Antiinflammatory Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Nonsteroidal Antiinflammatory Drugs (MT) of Key Companies (2015-2020)
Table 13. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Company (2015-2020)
Table 14. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Company (2015-2020)
Table 16. Global Nonsteroidal Antiinflammatory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Antiinflammatory Drugs as of 2019)
Table 17. Global Nonsteroidal Antiinflammatory Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Nonsteroidal Antiinflammatory Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Nonsteroidal Antiinflammatory Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Nonsteroidal Antiinflammatory Drugs Players
Table 22. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 23. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2015-2020)
Table 24. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Nonsteroidal Antiinflammatory Drugs Price (MT) by Type (2015-2020)
Table 26. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2021-2026)
Table 27. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2021-2026)
Table 29. Global Nonsteroidal Antiinflammatory Drugs Price (MT) by Type (2021-2026)
Table 30. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2015-2020)
Table 31. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Application (2015-2020)
Table 32. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Nonsteroidal Antiinflammatory Drugs Price (MT) by Application (2015-2020)
Table 34. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2021-2026)
Table 35. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Application (2021-2026)
Table 36. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Application (2021-2026)
Table 38. Global Nonsteroidal Antiinflammatory Drugs Price (MT) by Application (2021-2026)
Table 39. United States Nonsteroidal Antiinflammatory Drugs Sales (MT) by Company (2015-2020)
Table 40. United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 42. United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2015-2020)
Table 44. United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Nonsteroidal Antiinflammatory Drugs Sales (MT) by Company (2015-2020)
Table 46. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 48. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2015-2020)
Table 50. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 51. China Nonsteroidal Antiinflammatory Drugs Sales (MT) by Company (2015-2020)
Table 52. China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
Table 53. China Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 54. China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 55. China Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2015-2020)
Table 56. China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Nonsteroidal Antiinflammatory Drugs Sales (MT) by Company (2015-2020)
Table 58. Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 60. Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2015-2020)
Table 62. Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 69. India Nonsteroidal Antiinflammatory Drugs Sales (MT) by Company (2015-2020)
Table 70. India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2015-2020)
Table 71. India Nonsteroidal Antiinflammatory Drugs Sales (MT) by Type (2015-2020)
Table 72. India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 73. India Nonsteroidal Antiinflammatory Drugs Sales (MT) by Application (2015-2020)
Table 74. India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 75. Sanofi S.A. Corporation Information
Table 76. Sanofi S.A. Description and Business Overview
Table 77. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product
Table 79. Sanofi S.A. Recent Development
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novartis AG Nonsteroidal Antiinflammatory Drugs Product
Table 84. Novartis AG Recent Development
Table 85. GlaxoSmithKline PLC Corporation Information
Table 86. GlaxoSmithKline PLC Description and Business Overview
Table 87. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product
Table 89. GlaxoSmithKline PLC Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Nonsteroidal Antiinflammatory Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Nonsteroidal Antiinflammatory Drugs Product
Table 94. Pfizer Recent Development
Table 95. DOMESCO Corporation Information
Table 96. DOMESCO Description and Business Overview
Table 97. DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. DOMESCO Nonsteroidal Antiinflammatory Drugs Product
Table 99. DOMESCO Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Nonsteroidal Antiinflammatory Drugs Distributors List
Table 103. Nonsteroidal Antiinflammatory Drugs Customers List
Table 104. Nonsteroidal Antiinflammatory Drugs Market Key Trends
Table 105. Nonsteroidal Antiinflammatory Drugs Key Opportunities and Drivers
Table 106. Nonsteroidal Antiinflammatory Drugs Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Nonsteroidal Antiinflammatory Drugs Product Picture
Figure 2. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2020 & 2026
Figure 6. Osteoarthritis Examples
Figure 7. Muscle Aches Examples
Figure 8. Backaches Examples
Figure 9. Dental Pain Examples
Figure 10. Others Examples
Figure 11. Global Nonsteroidal Antiinflammatory Drugs Sales (MT) Growth Rate (2015-2026)
Figure 12. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Nonsteroidal Antiinflammatory Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Nonsteroidal Antiinflammatory Drugs Sales (MT) Growth Rate (2015-2026)
Figure 18. Europe Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Nonsteroidal Antiinflammatory Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Nonsteroidal Antiinflammatory Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Nonsteroidal Antiinflammatory Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Nonsteroidal Antiinflammatory Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Nonsteroidal Antiinflammatory Drugs Players Market Share by Revenue in Nonsteroidal Antiinflammatory Drugs 2015 & 2019
Figure 29. Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2015-2020)
Figure 31. Global Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Application (2015-2020)
Figure 33. Global Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 35. United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 36. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2019
Figure 37. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 38. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 39. China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2019
Figure 40. China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 41. China Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 42. Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2019
Figure 43. Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 44. Japan Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 45. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2019
Figure 46. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 47. Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 48. India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2019
Figure 49. India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 50. India Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Nonsteroidal Antiinflammatory Drugs
Figure 53. Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
Figure 54. Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …- 疼痛管理薬・デバイスの世界市場レポート2020 Market Analysis and Insights: Global Pain Management Drugs & Devices Market The global Pain Management Drugs & Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pain Management Drugs & Devices Scope and Market Siz…
- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…
- 筋弛緩薬の世界市場レポート2020 Market Analysis and Insights: Global Muscle Relaxant Drugs Market The global Muscle Relaxant Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Muscle Relaxant Drugs Scope and Market Size The global Muscle Relaxant D…
- 副腎白質ジストロフィー治療薬の世界市場レポート2020 Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP). Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatt…